FIELD: medicine.
SUBSTANCE: atherosclerotic plaques are stabilised by introduction of effective amount of 2-[4-[2-(benzimidazole-2-ylthio)ethyl]piperazine-1-yl]-N-[2,4-bis(methylthio)-6-methyl-3-pyridyl]acetamide, or the pharmaceutical composition containing effective amount of this compound as an active principle.
EFFECT: effective prevention of plaque destruction, their stabilisation ensured by reduced amount of macrophages and increased collagen fibres in atherosclerotic plaques.
12 cl, 7 dwg, 1 ex
